Supplementary Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

• DOI: 10.1158/1078-0432.22478822.v1
• Publication Date: 2023-04-01T13:54:29Z
• Authors: Fatima Karzai; Stephanie M. Walker; Scott Wilkinson; Ravi A. Madan; Joanna H. Shih; Maria J. Merino; Stephanie A. Harmon; David J. VanderWeele; Lisa M. Cordes; Nicole V. Carrabba; John R. Bright; Nicolas T. Terrigino; Guinevere Chun; Marijo Bilusic; Anna Couvillon; Amy Hankin; Monique N. Williams; Rosina T. Lis; Huihui Ye; Peter L. Choyke; James L. Gulley; Adam G. Sowalsky; Baris Turkbey; Peter A. Pinto; William L. Dahut

<p>Contains supplementary methods and 3 supplementary tables.</p>